Ajanta Pharma (AJP IN): Branded Generics Focus Ensures Consistent Growth
Strong presence in high growth Asia and Africa markets ensures healthy revenue growth in mid-term, while US business should be long-term value...
399 Views
Ipca Laboratories (IPCA IN): Domestic Business Is the Key Growth Driver
Ipca Laboratories is a fully-integrated generic pharmaceutical company. The company is outpacing the broader market due to its focus on fast moving...
173 Views
Global Equity Strategy U.S. Fed Cut, Now What?
With further consolidation likely for the broad indexes, we want to stick with areas of the market that have shown an ability to outperform despite...
428 Views
IPCA Laboratories- 2QFY19 Results – Growing While Awaiting USFDA Approvals
Ipca Laboratories (IPCA IN) 2QFY19 PAT of Rs 1,197 mn beat our estimates of Rs 1,023 mn. EBITDA margins, excluding forex loss, stood at 20.4%,...
413 Views
IPCA Labs: 1QFY19 Result - International Sales Decline but EBITDA Margins Improve
Ipca Laboratories (IPCA IN) reported revenue growth of 20% YoY at Rs. 8,427 mn, EBITDA at Rs. 1,140 mn and PAT at Rs. 655 mn in 1QFY19 led by low...
276 Views